drugset / Trial / NCT02026817

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

NCT02026817

Phase 1 Completed 36 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetic characteristics between HCP1201 tablet 750/10 mg and co-administration of metformin 750 mg plus rosuvastatin 10 mg under fed state condition.

Timeline

Start
2013-12
Primary completion
2013-12
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP1201 Unknown 10 mg Oral
Subject HCP1201 Unknown 750 mg Oral
Comparator Metformin Small molecule 750 mg Oral
Comparator Rosuvastatin Small molecule 10 mg Oral

Indications